Sternberg CN - Search Results

1

Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort.

Fornarini G, Rebuzzi SE, Banna GL, Calabrò F, Scandurra G, De Giorgi U, Masini C, Baldessari C, Naglieri E, Caserta C, Manacorda S, Maruzzo M, Milella M, Buttigliero C, Tambaro R, Ermacora P, Morelli F, Nolè F, Astolfi C, Sternberg CN. Fornarini G, et al. Among authors: sternberg cn. ESMO Open. 2021 Jun;6(3):100118. doi: 10.1016/j.esmoop.2021.100118. Epub 2021 May 10. ESMO Open. 2021. PMID: 33984678 Free PMC article.

2

Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder.

Sternberg CN, Pansadoro V, Calabro F, Marini L, van Rijn A, Carli PD, Giannarelli D, Platania A, Rossetti A. Sternberg CN, et al. Ann Oncol. 1999 Nov;10(11):1301-5. doi: 10.1023/a:1008350518083. Ann Oncol. 1999. PMID: 10631456 Free article. Clinical Trial.

3

Chemotherapy and management of bladder tumours.

Sternberg CN, Calabrò F. Sternberg CN, et al. BJU Int. 2000 Mar;85(5):599-610. doi: 10.1046/j.1464-410x.2000.00566.x. BJU Int. 2000. PMID: 10735935 Review. No abstract available.

4

Differences in gene expression in muscle-invasive bladder cancer: a comparison of Italian and American patients.

Williams SG, Gandour-Edwards R, Deitch AD, Toscano S, Fan JJ, Sternberg CN, Pansadoro V, Calabrò F, Rossetti A, deVere White RW. Williams SG, et al. Among authors: sternberg cn. Eur Urol. 2001 Apr;39(4):430-7. doi: 10.1159/000052481. Eur Urol. 2001. PMID: 11306882

5

Neo-adjuvant chemotherapy in invasive bladder cancer.

Sternberg CN, Calabrò F. Sternberg CN, et al. World J Urol. 2001 Apr;19(2):94-8. doi: 10.1007/s003450000190. World J Urol. 2001. PMID: 11374324 Review.

6

Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy.

Sternberg CN, Calabrò F, Pizzocaro G, Marini L, Schnetzer S, Sella A. Sternberg CN, et al. Cancer. 2001 Dec 15;92(12):2993-8. doi: 10.1002/1097-0142(20011215)92:12<2993::aid-cncr10108>3.0.co;2-2. Cancer. 2001. PMID: 11753976 Clinical Trial.

7

The management of bladder cancer in the elderly.

Sternberg CN, Calabrò F. Sternberg CN, et al. Tumori. 2002 Jan-Feb;88(1 Suppl 1):S128-9. doi: 10.1177/030089160208800138. Tumori. 2002. PMID: 11989905 No abstract available.

8

High-risk metastatic urothelial cancer: chances for cure?

Calabrò F, Sternberg CN. Calabrò F, et al. Among authors: sternberg cn. Curr Opin Urol. 2002 Sep;12(5):441-8. doi: 10.1097/00042307-200209000-00013. Curr Opin Urol. 2002. PMID: 12172434 Review.

9

Localized and locally advanced bladder cancer.

Calabrò F, Sternberg CN. Calabrò F, et al. Among authors: sternberg cn. Curr Treat Options Oncol. 2002 Oct;3(5):413-28. doi: 10.1007/s11864-002-0006-3. Curr Treat Options Oncol. 2002. PMID: 12194806 Review.

10

New drugs and new approaches for the treatment of metastatic urothelial cancer.

Calabrò F, Sternberg CN. Calabrò F, et al. Among authors: sternberg cn. World J Urol. 2002 Aug;20(3):158-66. doi: 10.1007/s00345-002-0275-2. Epub 2002 Jul 13. World J Urol. 2002. PMID: 12196899 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

466 results

Search Page